Ultragenyx Pharma (RARE) PT Raised to $68 at Jefferies; Reiterates Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Ultragenyx Pharma (RARE) PT Lowered to $79 at Morgan Stanley
May 8, 2017 9:08 AM EDTMorgan Stanley lowered its price target on Ultragenyx Pharma (NASDAQ: RARE) to $79.00 (from $84.00) while maintaining a Equalweight rating.
... MoreUltragenyx Pharma (RARE) Tops Q1 EPS by 8c
May 4, 2017 4:46 PM EDTUltragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.63), $0.08 better than the analyst estimate of ($1.71).
For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.
... More